标题
Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer
作者
关键词
-
出版物
JNCI-Journal of the National Cancer Institute
Volume 107, Issue 3, Pages -
出版商
Oxford University Press (OUP)
发表日期
2015-02-26
DOI
10.1093/jnci/dju427
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Use of epiregulin (EREG) and amphiregulin (AREG) gene expression to predict response to cetuximab (cet) in combination with oxaliplatin (Ox) and 5FU in the first-line treatment of advanced colorectal cancer (aCRC).
- (2017) Richard A. Adams et al. JOURNAL OF CLINICAL ONCOLOGY
- Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer
- (2013) M. K. Boisen et al. ANNALS OF ONCOLOGY
- Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum
- (2012) Mai Yamauchi et al. GUT
- Identification of a Poor-PrognosisBRAF-Mutant–Like Population of Patients With Colon Cancer
- (2012) Vlad Popovici et al. JOURNAL OF CLINICAL ONCOLOGY
- Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis
- (2012) J Verhulst et al. JOURNAL OF CLINICAL PATHOLOGY
- Evolution of the cancer genome
- (2012) Lucy R. Yates et al. NATURE REVIEWS GENETICS
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results
- (2011) J Cassidy et al. BRITISH JOURNAL OF CANCER
- Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer
- (2011) Ben Tran et al. CANCER
- A Review of Excision Repair Cross-complementation Group 1 in Colorectal Cancer
- (2011) Pierre Bohanes et al. Clinical Colorectal Cancer
- Comparison of 17,641 Patients With Right- and Left-Sided Colon Cancer: Differences in Epidemiology, Perioperative Course, Histology, and Survival
- (2011) Frank Benedix et al. DISEASES OF THE COLON & RECTUM
- Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
- (2011) Gordon Hutchins et al. JOURNAL OF CLINICAL ONCOLOGY
- Mortality by Stage for Right- Versus Left-Sided Colon Cancer: Analysis of Surveillance, Epidemiology, and End Results–Medicare Data
- (2011) Jennifer M. Weiss et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy
- (2011) F. A. Sinicrope et al. JNCI-Journal of the National Cancer Institute
- Implementing prognostic and predictive biomarkers in CRC clinical trials
- (2011) Sandra Van Schaeybroeck et al. Nature Reviews Clinical Oncology
- TS and ERCC-1 mRNA expressions and clinical outcome in patients with metastatic colon cancer in CONFIRM-1 and -2 clinical trials
- (2011) P P Grimminger et al. PHARMACOGENOMICS JOURNAL
- Predictive and Prognostic Markers in Colorectal Cancer
- (2011) Ben George et al. Current Oncology Reports
- Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer
- (2009) J Souglakos et al. BRITISH JOURNAL OF CANCER
- Molecular Basis of Colorectal Cancer
- (2009) Sanford D. Markowitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Is There a Difference in Survival Between Right- Versus Left-Sided Colon Cancers?
- (2008) Robert A. Meguid et al. ANNALS OF SURGICAL ONCOLOGY
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search